157 related articles for article (PubMed ID: 21233249)
1. Indications for minimally invasive surgery for ovarian cancer.
Han ES; Wakabayashi M
J Natl Compr Canc Netw; 2011 Jan; 9(1):126-32. PubMed ID: 21233249
[TBL] [Abstract][Full Text] [Related]
2. The role of minimally invasive interval debulking surgery in advanced epithelial ovarian cancer.
Menderes G; Black JD; Azodi M
Expert Rev Anticancer Ther; 2016 Sep; 16(9):899-901. PubMed ID: 27477495
[No Abstract] [Full Text] [Related]
3. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.
Fagotti A; Perelli F; Pedone L; Scambia G
Curr Treat Options Oncol; 2016 Jan; 17(1):3. PubMed ID: 26739150
[TBL] [Abstract][Full Text] [Related]
4. Role of minimally invasive surgery in ovarian cancer.
Nezhat FR; Pejovic T; Finger TN; Khalil SS
J Minim Invasive Gynecol; 2013; 20(6):754-65. PubMed ID: 24183269
[TBL] [Abstract][Full Text] [Related]
5. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
[TBL] [Abstract][Full Text] [Related]
6. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
7. Timing of debulking surgery in advanced ovarian cancer.
Vergote I; van Gorp T; Amant F; Leunen K; Neven P; Berteloot P
Int J Gynecol Cancer; 2008; 18 Suppl 1():11-9. PubMed ID: 18336393
[TBL] [Abstract][Full Text] [Related]
8. Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer.
Chern JY; Curtin JP
Curr Treat Options Oncol; 2016 Jan; 17(1):1. PubMed ID: 26714493
[TBL] [Abstract][Full Text] [Related]
9. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.
Cardenas-Goicoechea J; Wang Y; McGorray S; Saleem MD; Carbajal Mamani SL; Pomputius AF; Markham MJ; Castagno JC
J Robot Surg; 2019 Feb; 13(1):23-33. PubMed ID: 29992404
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy.
May T; Comeau R; Sun P; Kotsopoulos J; Narod SA; Rosen B; Ghatage P
Int J Gynecol Cancer; 2017 May; 27(4):668-674. PubMed ID: 28441250
[TBL] [Abstract][Full Text] [Related]
12. The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Cancer Treat Res; 2007; 134():387-402. PubMed ID: 17633068
[No Abstract] [Full Text] [Related]
13. [Advanced ovarian cancer: primary debulking (PDS) or neoadjuvant chemotherapy (NACT) - still a debate].
Segev Y; Gemer O; Auslender R; Lavie O
Harefuah; 2014 Sep; 153(9):527-31, 558. PubMed ID: 25417489
[TBL] [Abstract][Full Text] [Related]
14. Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis.
Bogani G; Borghi C; Leone Roberti Maggiore U; Ditto A; Signorelli M; Martinelli F; Chiappa V; Lopez C; Sabatucci I; Scaffa C; Indini A; Ferrero S; Lorusso D; Raspagliesi F
J Minim Invasive Gynecol; 2017; 24(4):552-562. PubMed ID: 28223182
[TBL] [Abstract][Full Text] [Related]
15. The utility of hand-assisted laparoscopy in ovarian cancer.
Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
[TBL] [Abstract][Full Text] [Related]
17. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
Davidson BA; Broadwater G; Crim A; Boccacio R; Bixel K; Backes F; Previs RA; Salinaro J; Salani R; Moore K; Secord AA
Gynecol Oncol; 2019 Mar; 152(3):554-559. PubMed ID: 30558972
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of Iranian patients with advanced ovarian cancer with neoadjuvant chemotherapy versus primary debulking surgery.
Ghaemmaghami F; Karimi-Zarchi M; Modares-Gilani M; Mousavi A; Behtash N
Asian Pac J Cancer Prev; 2008; 9(4):719-24. PubMed ID: 19256766
[TBL] [Abstract][Full Text] [Related]
19. Role of minimally invasive surgery in staging of ovarian cancer.
Iglesias DA; Ramirez PT
Curr Treat Options Oncol; 2011 Sep; 12(3):217-29. PubMed ID: 21503633
[TBL] [Abstract][Full Text] [Related]
20. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
